by Dave Rushton | 30 May 2016 | Good Distribution Practice, MHRA
List of Controlled Substances Well, it has been a long time coming, but the Home Office have now re-posted the list of controlled substances which has been down for over a year....
by Dave Rushton | 23 May 2016 | Good Distribution Practice, MHRA, Standard Operating Procedures
Do you supply medicines as stock to other healthcare providers or other legal entities by way of wholesale dealing? You may be aware you need to hold a Wholesale Distribution Authorisation or WDA (H) if you supply medicines as stock to another legal entity, but do you...
by Dave Rushton | 19 May 2016 | Good Distribution Practice, Industry, MHRA, Risk Management
The Falsified Medicines Directive is a key focus for the UK Competent Authority (the MHRA) and it is expected that as a UK Pharmaceutical wholesaler that you are aware of this emerging regulation. The FMD comes into effect 09 Feb 2019, “Brexit” or not. For...
by Dave Rushton | 18 May 2016 | Good Distribution Practice, Industry, MHRA, Training
Falsified Medicines An update on the Falsified Medicines Directive from Sultan “SID” Dajani, Chairman of the Falsified Medicines Directive at the Royal Pharmaceutical Society and UK Representative for the Pharmacy Group of the European Union (PGEU). “With the...
by Dave Rushton | 9 May 2016 | Good Distribution Practice, Paradigm Updates, Training
Are you planning on becoming a Responsible Person for a pharmaceutical wholesaler? Do you fit the criteria laid out by the National Competent Authority, the MHRA? The Gold Standard for Responsible Persons has been in laid out for over two years at the date of writing...